The current status and future impact of targeted therapies in non-Hodgkin lymphoma

By Ujjani Chaitra   Cheson Bruce D  

Expert Review of Hematology, Vol. 6, Iss. 2, 2013-04 ,pp. : 191-203

Informa Healthcare

Access to resources Recommend Favorite

The Effects of CD26/DPP IV-Targeted Therapy on Acute Allograft Rejection

By Korom S.   De Meester I.   Onodera K.   Stadlbauer T.H.W.   Borloo M.   Lambeir A.M.   Kupiec-Weglinski J.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1274-1275

Elsevier

Access to resources Recommend Favorite

Misjudgement of gefitinib efficacy in patients with central non-smallcell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 535-538

Spandidos Publications

Access to resources Recommend Favorite

Molecular Pathogenesis of Non Muscle-Invasive Bladder Cancer: Implications for Novel Targeted Therapies

By  

Current Molecular Medicine, Vol. 11, Iss. 8, 2011-11 ,pp. : 623-632

Bentham Science Publishers

Access to resources Recommend Favorite

Low-dose radiation effects: Experimental hematology and the changing paradigm

By Mothersill C.   Seymour C.  

Experimental Hematology, Vol. 31, Iss. 6, 2003-06 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite